Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls
Chen et al., eBioMedicine, doi:10.1016/j.ebiom.2024.105042
https://c19early.org/chen17.html